Chest health - Pharmion Expects Revenue Growth in 2007
Pharmion Expects Revenue Growth in 2007
Forbes - Drug developer Pharmion Corp. said Wednesday it expects revenue to rise between 1 percent and 5 percent in 2007, driven by sales of its lung cancer treatment Amrubicin. The company said it expects revenue of $240 million to $250 million in the full
The second-largest spectator sport in the nation and our state is
Seattle Times - No wonder some of their drivers die early of lung cancer and lead poisoning. The fearless (if not suicidal) drivers tailgate each other horribly and continuously at 150 mph and offer a disgusting role model for the rest of us drivers out on the freeway
CAW blames Marystown, Nfld., shipyard toxic exposure for 15 cancer
Canada East - The claims submitted to the Workplace Health, Safety and Compensation Commission cover seven cases of lung cancer and eight of various gastrointestinal cancers blamed on exposure to asbestos in the workplace. "There is no question in my mind that some
